INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined tomatoes. Clear

32 studies · page 2 of 2

2007 / Randomized controlled trial

Tomato extract improved nasal symptoms and quality of life in allergic rhinitis.

Thirty-three patients with perennial allergic rhinitis were randomized to take 360 mg per day of oral tomato extract or placebo for 8 weeks. Sneezing scores (p < 0.05) and combined total symptom scores (p < 0.01) decreased significantly after 8 weeks of tomato extract. Quality of life also improved significantly in the extract group (p < 0.05), whereas no improvement occurred in the placebo group.

Yoshimura M, Enomoto T, Dake Y, et al. Allergol Int, 2007. PMID 17519582

2006 / Randomized crossover trial

Tomato extract supplements acutely decreased ex vivo platelet aggregation in healthy adults.

In a randomized, double-blinded, placebo-controlled crossover study of 90 healthy subjects, acute effects of tomato extract doses equivalent to two or six tomatoes were evaluated at 3 hours. Both doses significantly lowered platelet aggregation induced by ADP (up to -21.3%; P < 0.001) and collagen (up to -17.5%; P = 0.007). Platelet inhibition was strongest in individuals displaying higher baseline plasma homocysteine and C-reactive protein levels.

O'Kennedy N, Crosbie L, Whelan S, et al. Am J Clin Nutr, 2006. PMID 16960170

2006 / Clinical trial

Tomato extract beverage significantly suppressed platelet function ex vivo in healthy adults.

A time-course study in 23 cannulated healthy participants assessed the ex vivo effects of a tomato extract drink equivalent to six tomatoes. Three hours post-intake, baseline platelet aggregation was inhibited by 2.9 ± 1.4% (optimal ADP, P = 0.03) to 20.0 ± 4.9% (suboptimal ADP, P < 0.001). Significant antiplatelet effects persisted for more than 12 hours, while blood coagulation variables were not altered.

O'Kennedy N, Crosbie L, van Lieshout M, et al. Am J Clin Nutr, 2006. PMID 16960171

2003 / Randomized crossover trial

Carotenoid-rich vegetable juices modulated immune markers in men on low-carotenoid diets.

A randomized crossover study gave healthy men on a low-carotenoid diet 330 ml daily of tomato juice or carrot juice for two weeks, separated by two-week depletion intervals. Plasma carotenoid concentrations rose rapidly (P < 0.0002) without concurrent immune alterations. Peak responses for IL-2, natural killer cell cytotoxicity, and lymphocyte proliferation appeared during the depletion phases, while IL-4 secretion was unaffected.

Watzl B, Bub A, Briviba K, et al. Ann Nutr Metab, 2003. PMID 14520020

2002 / Nonrandomized single-arm intervention trial

Tomato sauce consumption increased prostate lycopene and reduced DNA damage biomarkers and PSA in men with prostate cancer.

Thirty-two patients with localized prostate adenocarcinoma consumed tomato sauce-based pasta dishes providing 30 mg lycopene daily for 3 weeks before radical prostatectomy. Serum and prostate lycopene increased 1.97- and 2.92-fold, respectively (P < 0.001), while mean serum PSA decreased by 17.5% (P < 0.002) and leukocyte 8OHdG decreased by 21.3% (P < 0.005). Resected tissues showed 28.3% lower prostate 8OHdG than controls (P < 0.03), and cancer cell 8OHdG staining was reduced by 40.5% in mean nuclear density and 36.4% in mean area compared to baseline biopsy.

Bowen P, Chen L, Stacewicz-Sapuntzakis M, et al. Exp Biol Med (Maywood), 2002. PMID 12424330

2001 / Interventional study (pre-post with comparison group)

Tomato sauce consumption increased lycopene levels and reduced oxidative DNA damage and serum PSA in prostate cancer patients.

Thirty-two patients with localized prostate cancer consumed tomato sauce-based pasta dishes (30 mg lycopene/day) for 3 weeks prior to prostatectomy. Following the intervention, serum lycopene significantly rose from 638 to 1258 nM and prostate lycopene increased from 0.28 to 0.82 nmol/g (both P<.001). Leukocyte oxidative DNA damage decreased from 0.61 to 0.48 8-OHdG/10^5 dG (P=.005), and prostate tissue oxidative DNA damage was significantly lower in participants compared to 7 randomly selected patients (0.76 vs. 1.06 8-OHdG/10^5 dG, P=.03). Serum PSA levels dropped significantly from 10.9 ng/mL to 8.7 ng/mL (P<.001).

Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. J Natl Cancer Inst, 2001. PMID 11752012

1999 / Controlled trial

Tomato juice restored T-lymphocyte cytokine secretion suppressed by a low-carotenoid diet.

Twenty-three non-smoking men followed a 2-week low-carotenoid diet followed by sequential 2-week periods consuming tomato juice, carrot juice, and spinach powder. The low-carotenoid period significantly suppressed peripheral blood mononuclear cell proliferation and cytokine secretion (IL-2, P < 0.001; IL-4, P < 0.05). Adding tomato juice restored IL-2 (P < 0.001) and IL-4 (P < 0.05) secretion, whereas carrot juice and spinach powder produced no significant changes.

Watzl B, Bub A, Brandstetter BR, et al. Br J Nutr, 1999. PMID 10673911

1985 / Experimental feeding study in rats and humans

Tomato lectin resists digestion in the alimentary canal and binds intestinal villi, showing low absorption into human circulation.

Experiments investigated whether orally consumed tomato lectin resists digestion and functions within the alimentary canal. In rats fed a tomato lectin-rich diet, serologically detectable tomato lectin was found in faeces and bound to intestinal villi, with radioactivity mostly recovered from the alimentary canal and only traces in circulation or internal organs 3 hours after 125I-labelled lectin administration. Similarly, radioactivity absorbed into the human circulation after consuming 125I-labelled tomato lectin was less than expected for a digestible protein.

Kilpatrick DC, Pusztai A, Grant G, et al. FEBS Lett, 1985. PMID 3888674